Norton Peet Phones & Addresses
-
885 Bay Ridge Dr, Holland, MI 49424
-
Central Lake, MI
-
19 Presidential Way, Woburn, MA 01801
-
Cincinnati, OH
-
50 Blue Ridge Rd, North Andover, MA 01845 (978) 685-3734 (978) 685-7619
-
Branchburg, NJ
-
West Chester, OH
-
50 Blue Ridge Rd, North Andover, MA 01845 (978) 270-6262
Work
Company:
Creagen biosciences inc
Address:
23 Rainin Rd, Woburn, MA 01801
Phones:
(781) 938-1122
Position:
Chairman
Industries:
Commercial Physical and Biological Research
Education
Degree:
Associate degree or higher
Emails
n***1@ameritech.net
Business Records
Name / Title
Company / Classification
Phones & Addresses
Chairman
Creagen Biosciences Inc
Commercial Physical and Biological Research
Commercial Physical and Biological Research
23 Rainin Rd, Woburn, MA 01801
Chairman
CreaGen Biosciences, Inc.
Biotechnology · Commercial Physical Research
Biotechnology · Commercial Physical Research
23 Rainin Rd, Woburn, MA 01801
(781) 938-1122, (781) 938-1123
(781) 938-1122, (781) 938-1123
Chief Executive Officer
Aurigene Discovery Technologies
Mfg Pharmaceutical Preparations
Mfg Pharmaceutical Preparations
99 Hayden Ave, Lexington, MA 02421
(781) 541-6727
(781) 541-6727
Board of Directors
Defense Contract Audit Agency
Defense Contract Audit Office · Personal Service Agents Brokers and Bureaus
Defense Contract Audit Office · Personal Service Agents Brokers and Bureaus
59 Lowes Way, Lowell, MA 01851
(978) 551-9748, (978) 551-9898, (978) 551-9710
(978) 551-9748, (978) 551-9898, (978) 551-9710
Publications
Us Patents
20-Fluoro-17(20)-Vinyl Steroids
View pageUS Patent:
6413951, Jul 2, 2002
Filed:
Jun 21, 2001
Appl. No.:
09/886818
Inventors:
Norton P. Peet - North Andover MA
Philip M. Weintraub - Warren NJ
Joseph P. Burkhart - Plainfield IN
Cynthia A. Gates - Cambridge MA
Philip M. Weintraub - Warren NJ
Joseph P. Burkhart - Plainfield IN
Cynthia A. Gates - Cambridge MA
Assignee:
Aventis Pharmaceuticals, Inc. - Bridgewater NJ
International Classification:
A61K 3156
US Classification:
514177, 514182, 552515, 552530, 552532
Abstract:
The invention relates to 20 -fluoropregna-4,17(20)-dien-3-on-21-oic acid ethyl ester, 20 -fluoro-3-hydroxypregna-5,17(20)-dien-21-oic acid ethyl ester, 20 -fluoro-21-hydroxypregna-4,17 (20)-dien-3-one, 20 -fluoropregna-5,17(20)-dien-3,21-diol and related compounds and to compositions incorporating these compounds, as well as the inhibition of C lyase, 5-reductase and C -hydroxylase, and to the use of these compounds in the treatment of androgen and estrogen mediated or dependent disorders, including benign prostatic hyperplasia, prostate cancer, breast cancer and DHT-mediated disorders such as acne and hirsutism. Treatment of disorders related to the over synthesis of cortisol, for example, Cushings Syndrome are also included. The treatment of androgen-dependent disorders also includes a combination therapy with known androgen-receptor antagonists, such as flutamide. The compounds of the invention have the following general formulae:.
6,9-Disubstituted 2-[Trans-(4-Aminocyclohexyl)Amino] Purines
View pageUS Patent:
6642231, Nov 4, 2003
Filed:
Jun 24, 2002
Appl. No.:
10/178494
Inventors:
Jennifer A. Dumont - Groton MA
Alan J. Bitonti - Acton MA
David R. Borcherding - Bangor PA
Norton P. Peet - North Andover MA
Patrick W. Shum - Flemington NJ
Alan J. Bitonti - Acton MA
David R. Borcherding - Bangor PA
Norton P. Peet - North Andover MA
Patrick W. Shum - Flemington NJ
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C07D47316
US Classification:
5142342, 5142634, 51426321, 51426322, 51426333, 5142632, 544118, 544277
Abstract:
The present invention comprises 6-9-Disubstituted 2-[trans-(4-aminocyclohexyl]aminopurines that are useful in inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms.
Elastase Inhibitors
View pageUS Patent:
6693072, Feb 17, 2004
Filed:
Dec 20, 2000
Appl. No.:
09/741536
Inventors:
Steven L. Gallion - Woburn MA
William A. Metz Jr. - Loveland OH
Joseph P. Burkhart - Plainfield IN
Michael R. Angelastro - Mason OH
Norton P. Peet - Cincinnati OH
William A. Metz Jr. - Loveland OH
Joseph P. Burkhart - Plainfield IN
Michael R. Angelastro - Mason OH
Norton P. Peet - Cincinnati OH
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 3800
US Classification:
514 2, 514 18, 514 19, 530330, 530331
Abstract:
This invention relates to compounds which are inhibitors of elastase, particularly human neutrophil elastase. The inhibitors are short, synthetic peptides in which the P moiety is substituted with various nitrogen-containing heterocyclic groups. As inhibitors of human neutrophil elastase, the compounds are useful in the treatment of a patient afflicted with a neutrophil associated inflammatory disease.
Acyl And Sulfonyl Derivatives Of 6,9-Disubstituted 2-(Trans-1,4-Diaminocyclohexyl)-Purines And Their Use As Antiproliferative Agents
View pageUS Patent:
6861524, Mar 1, 2005
Filed:
Oct 31, 2001
Appl. No.:
09/998976
Inventors:
David Borcherding - Bangor PA, US
Jennifer A. Dumont - Groton MA, US
Norton P. Peet - North Andover MA, US
Paul S. Wright - New Hope PA, US
Jennifer A. Dumont - Groton MA, US
Norton P. Peet - North Andover MA, US
Paul S. Wright - New Hope PA, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C07D473/16
A61K031/52
A61P035/00
A61P037/06
A61K031/52
A61P035/00
A61P037/06
US Classification:
544277
Abstract:
The present invention is directed to acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines of the formula where Z is selected from the group consisting of —S(O)—, and —C(O)—.
Acyl And Sulfonyl Derivatives Of 6,9-Disubstituted 2-(Trans-1,4-Diaminocyclohexyl)-Purines And Their Use As Antiproliferative Agents
View pageUS Patent:
7429595, Sep 30, 2008
Filed:
Oct 2, 2003
Appl. No.:
10/677683
Inventors:
David Borcherding - Bangor PA, US
Jennifer A. Dumont - Groton MA, US
Norton P. Peet - North Andover MA, US
Paul S. Wright - New Hope PA, US
Jennifer A. Dumont - Groton MA, US
Norton P. Peet - North Andover MA, US
Paul S. Wright - New Hope PA, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C07D 473/16
A61K 31/52
A61P 35/00
A61P 35/02
A61K 31/52
A61P 35/00
A61P 35/02
US Classification:
51426322, 544277
Abstract:
The present invention is directed to acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4 -diaminocyclohexyl)-purines of the formula.
Ampk Modulators
View pageUS Patent:
8273744, Sep 25, 2012
Filed:
Feb 4, 2009
Appl. No.:
12/365671
Inventors:
Neal C. Birnberg - Lexington MA, US
Hong Liu - Wilmington MA, US
Qing Ping Weng - Wellesley MA, US
Haibo Shang - North Reading MA, US
Pan Yin - Billerica MA, US
Sharanappa B. Rajur - Andover MA, US
Hwa-Ok Kim - Lexington MA, US
Paresh D. Salgaonkar - Malden MA, US
Norton P. Peet - North Andover MA, US
Hong Liu - Wilmington MA, US
Qing Ping Weng - Wellesley MA, US
Haibo Shang - North Reading MA, US
Pan Yin - Billerica MA, US
Sharanappa B. Rajur - Andover MA, US
Hwa-Ok Kim - Lexington MA, US
Paresh D. Salgaonkar - Malden MA, US
Norton P. Peet - North Andover MA, US
Assignee:
Mercury Therapeutics, Inc. - Woburn MA
International Classification:
A01N 43/58
A01N 43/42
A01N 43/38
A61K 43/60
A61K 31/44
A61K 31/405
C07D 471/00
C07D 215/00
C07D 209/04
A01N 43/42
A01N 43/38
A61K 43/60
A61K 31/44
A61K 31/405
C07D 471/00
C07D 215/00
C07D 209/04
US Classification:
514249, 514300, 514312, 514415, 544350, 546155, 548469
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts, esters and prodrugs of Formula (I) or (II):.
Inhibitors Of Bacterial Biofilm Formation
View pageUS Patent:
20110098323, Apr 28, 2011
Filed:
May 19, 2009
Appl. No.:
12/991675
Inventors:
Timothy J. Opperman - Arlington MA, US
John D. Williams - Worcester MA, US
Norton P. Peet - North Andover MA, US
Atiyya R. Khan - Shrewsbury MA, US
Steven M. Kwasny - Millbury MA, US
John D. Williams - Worcester MA, US
Norton P. Peet - North Andover MA, US
Atiyya R. Khan - Shrewsbury MA, US
Steven M. Kwasny - Millbury MA, US
Assignee:
MICROBIOTIX, INC. - Worcester MA
International Classification:
A01N 43/40
A01N 43/78
A01N 43/08
A01N 43/50
A01P 1/00
A01N 43/78
A01N 43/08
A01N 43/50
A01P 1/00
US Classification:
514342, 514369, 514473, 514391
Abstract:
Organic compounds are described for use in inhibiting or preventing formation of bacterial biofilms.
Compositions Including 6-Aminohexanoic Acid Derivatives As Hdac Inhibitors
View pageUS Patent:
20120094971, Apr 19, 2012
Filed:
Sep 3, 2009
Appl. No.:
13/062030
Inventors:
James R. Rusche - Waltham MA, US
Norton P. Peet - North Andover MA, US
Allen T. Hopper - Katonah NY, US
Norton P. Peet - North Andover MA, US
Allen T. Hopper - Katonah NY, US
Assignee:
REPLIGEN CORPORATION - Waltham MA
International Classification:
A61K 31/397
A61K 31/167
C07D 277/56
A61K 31/426
C07D 295/15
A61K 31/5375
C07C 311/46
A61K 31/18
C07D 209/48
A61K 31/4035
C07D 217/24
A61K 31/472
C07D 241/24
A61K 31/4965
C07D 241/42
A61K 31/498
C07D 237/30
A61K 31/502
C12N 9/99
A61P 35/00
A61P 29/00
A61P 25/14
A61P 25/00
A61P 21/00
A61P 25/28
A61P 43/00
C07C 237/52
A61K 31/167
C07D 277/56
A61K 31/426
C07D 295/15
A61K 31/5375
C07C 311/46
A61K 31/18
C07D 209/48
A61K 31/4035
C07D 217/24
A61K 31/472
C07D 241/24
A61K 31/4965
C07D 241/42
A61K 31/498
C07D 237/30
A61K 31/502
C12N 9/99
A61P 35/00
A61P 29/00
A61P 25/14
A61P 25/00
A61P 21/00
A61P 25/28
A61P 43/00
C07C 237/52
US Classification:
51421001, 564157, 514616, 548200, 514365, 544165, 5142378, 564 92, 514604, 548477, 514417, 546141, 514309, 544406, 51425506, 544353, 514249, 544237, 514248, 435184
Abstract:
This invention relates to compounds of Formula (I) wherein Cy, L, Y, R, L, and Arare defined herein, for the treatment of cancers, inflammatory disorders, and neurological conditions.